An antiphospholipid antibody found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications
1
Anticoagulantia. : Anticoagulants, antiplatelets, and thrombolytics / edited by Shaker A. Mousa
Anticoagulants (Medicina) : Direct oral anticoagulants : from pharmacology to clinical practice / Riccardo Proietti, Ahmed AlTurki, Nicola Ferri, Vincenzo Russo, T. Jared Bunch, editors
Anticonvulsants -- Dictionaries : Epilepsy A to Z : a concise encyclopedia / William O. Tatum IV, Peter W. Kaplan, Pierre Jallon
2009
1
Anticonvulsants -- economics. : Economic evaluation of epilepsy management : proceedings of the Symposium on Economic Aspects of Epilepsy at the 21st International Epilepsy Congress in Sydney, 5 September 1995 / edited by Christoph Pachlatko, Roy G. Beran
Drugs used to prevent SEIZURES or reduce their severity
1
Anticorpo e imuneglobulina. : Monoclonal antibodies : principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry and immunology / James W. Goding
1996
1
Anticorpos (genética) : Antibody engineering : methods and protocols / edited by Benny K.C. Lo
2004
1
Anticorps anti-VHC. : Hepatitis C protocols / edited by Johnson Yiu-Nam Lau ; forewords by T. Jake Liang [and others]
1998
1
Anticorps monoclonal. : Monoclonal antibodies : a practical approach / edited by Philip Shepherd and Christopher Dean
2000
1
Anticorps monoclonaux. : Monoclonal antibodies : a practical approach / edited by Philip Shepherd and Christopher Dean
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems
